EBITDA jumped 40% to Rs 281.6 crore in Q3 FY26, registering the growth of 40% compared with Rs 271.8 crore in Q3 FY25.EBITDA margin improved to 34.6% in Q3 FY26 as against 30.5% in Q3 FY25.
Sachin K. Gupta, founder & Global CEO, IKS Health,said, “'Our strong Q3 performance, characterized by 24% revenue growth, validatesthat our Care Enablement Platform is the critical solution for a US healthcare market facing a perfect storm of cost, quality, and access pressures. As physician marginsface renewed compression from stagnant reimbursement rates, we are seeing this act as a powerful catalyst for increased outsourcing and platform adoption.
We continue to deepen our value proposition by advancing our AI capabilities—specifically moving our Patient Engagement suite toward multi-agent orchestration—to drive cognitive reasoning and independent action. Our recent wins with partners like StrideCare and VitalMD demonstrate that provider enterprises are increasingly choosing our integrated platform to ensure their financial sustainability and clinical efficiency.”
Nithya Balasubramanian, Group CFO, IKS Health said, “Our Q3 FY2026 performance underscores our consistent ability to drive profitable growth and deliver significant value to our clients. We achieved a 24% year-on-year revenue increase and a 41% growth in Profit After Tax (PAT), fueled by continuous expansion across existing and new client relationships. Margin expansion is a direct result of our successful operating leverage, technology deployment and focused cost management. ”
Inventurus Knowledge Solutions (IKS Health) is a leading technology enabled healthcare solutions provider, primarily serving the US healthcare market. It offers a comprehensive care enablement platform that supports healthcare enterprises across outpatient and inpatient care settings.
"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."